← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Adaptive Biotechnologies Corporation
Seattle, WA
$3,986,240
Total funding
6
Grants
Funding over time
peak $1.4M · FY2010–17$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,986,240 · 6
By mechanism
R44$2,528,467 · 1
R43$1,191,574 · 4
N43$266,199 · 1
Investigators at Adaptive Biotechnologies Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Correlating TCR diversity to immune reconstitution after cord blood transplant$1,057,509
R44 · FY2015 · HL
Correlating TCR diversity to immune reconstitution after cord blood transplant$951,199
R44 · FY2013 · HL
Correlating TCR diversity to immune reconstitution after cord blood transplant$519,759
R44 · FY2017 · HL
Development of T-cell receptor repertoire profiling as a diagnostic for T1D$332,770
R43 · FY2010 · DK
Development of T-cell receptor repertoire profiling as a diagnostic for T1D$299,915
R43 · FY2011 · DK
An Immune Repertoire Deep Sequencing Companion Diagnostic for lpilimumab$266,199
N43 · FY2013 · CA
Non-invasive Diagnostic Platform Development for Celiac Disease Remission Status$244,699
R43 · FY2014 · AI
Minimal Residual Disease Monitoring by T-cell Receptor Repertoire Profiling$165,191
R43 · FY2013 · CA
Correlating TCR diversity to immune reconstitution after cord blood transplant$148,999
R43 · FY2011 · HL